Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Interim Chief Medical Officer

See Remarks

President and CEO

Chief Medical Officer

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's lead product includes fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and Plogosertib, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced leukemias and solid tumors. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. The company was founded in 1996 and is headquartered in Berkeley Heights, New Jersey.

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proli...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-29	Premium	acquired	Premium	Premium	Premium	Interim Chief Medical Officer
2023-12-21	Premium	bought	Premium	Premium	Premium	See Remarks
2023-12-21	Premium	bought	Premium	Premium	Premium	President and CEO
2023-06-30	Premium	acquired	Premium	Premium	Premium	-
2023-06-30	Premium	acquired	Premium	Premium	Premium	-
2023-06-30	Premium	acquired	Premium	Premium	Premium	-
2023-06-30	Premium	acquired	Premium	Premium	Premium	-
2023-06-30	Premium	acquired	Premium	Premium	Premium	-
2023-06-30	Premium	acquired	Premium	Premium	Premium	-
2023-01-31	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-01-31	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-01-31	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-06-14	Premium	acquired	Premium	Premium	Premium	-
2022-06-14	Premium	acquired	Premium	Premium	Premium	-
2022-06-14	Premium	acquired	Premium	Premium	Premium	-
2022-06-14	Premium	acquired	Premium	Premium	Premium	-
2022-06-14	Premium	acquired	Premium	Premium	Premium	-
2022-06-14	Premium	acquired	Premium	Premium	Premium	-
2022-06-14	Premium	acquired	Premium	Premium	Premium	-
2022-06-14	Premium	acquired	Premium	Premium	Premium	-
2021-11-30	Premium	sold	Premium	Premium	Premium	-
2021-11-18	Premium	bought	Premium	Premium	Premium	President and CEO
2021-08-24	Premium	bought	Premium	Premium	Premium	-
2021-06-15	Premium	acquired	Premium	Premium	Premium	-
2021-06-15	Premium	acquired	Premium	Premium	Premium	-

CYCC - Cyclacel Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for CYCC